Alba Gonzàlez-Juncà
Impact in
- Oncology top 10%
- Cancer-related Molecular Pathways
- Cancer Cells and Metastasis
Papers in
-
- TGF-β signaling in diseases 5
- Ubiquitin and proteasome pathways 2
- Oncology 6
- Cancer Cells and Metastasis 5
- Chemokine receptors and signaling 1
- Clusterin in disease pathology 1
- Co-authors
- Joan Seoane (7 shared papers)Laura Rodón (4 shared papers)Elena Martínez‐Sáez (3 shared papers)Isabel Cuartas (4 shared papers)José Jimenez (1 shared paper)David García‐Dorado (1 shared paper)Annette M.G. Dirac (1 shared paper)José Baselga (1 shared paper)
- Journals
- International Journal of Radiation Oncology*Biology*Physics (2 papers)Nature Communications (1 paper)Neuro-Oncology (1 paper)Clinical Cancer Research (1 paper)Nature Medicine (1 paper)
- Partner nations
- United StatesSpainItaly
In The Last Decade
Alba Gonzàlez-Juncà
13 papers receiving 704 citations
Peers
Comparison fields: 5 of 65
- Oncology 233
- Cancer Research 118
- Molecular Biology 510
- Genetics 63
- Immunology 92
Countries citing papers authored by Alba Gonzàlez-Juncà
This map shows the geographic impact of Alba Gonzàlez-Juncà's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alba Gonzàlez-Juncà with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alba Gonzàlez-Juncà more than expected).
Fields of papers citing papers by Alba Gonzàlez-Juncà
This network shows the impact of papers produced by Alba Gonzàlez-Juncà. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alba Gonzàlez-Juncà. The network helps show where Alba Gonzàlez-Juncà may publish in the future.
Co-authors
The 25 scholars most cited alongside Alba Gonzàlez-Juncà, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 335 | |
| 2 | 2014 | 149 | |
| 3 | 2014 | 69 | |
| 4 | 2018 | 68 | |
| 5 | 2015 | 29 | |
| 6 | 2019 | 19 | |
| 7 | 2020 | 14 | |
| 8 | 2021 | 13 | |
| 9 | Receptor Inhibitors Target the CD44(high)/Id1(high) Glioma-Initiating Cell Population in Human Glioblastoma | 2010 | 5 |
| 10 | 2012 | 3 | |
| 11 | 2019 | 2 | |
| 12 | 2010 | 1 | |
| 13 | 2013 | 1 |
About Alba Gonzàlez-Juncà
Alba Gonzàlez-Juncà is a scholar working on Molecular Biology, Oncology, Cancer Research, Cell Biology and Neurology, having authored 13 papers that have together received 708 indexed citations. Recurring topics across this work include TGF-β signaling in diseases (5 papers), Cancer Cells and Metastasis (5 papers), Cancer, Hypoxia, and Metabolism (3 papers), Ubiquitin and proteasome pathways (2 papers), Cell Adhesion Molecules Research (2 papers), Chemokine receptors and signaling (1 paper), Microtubule and mitosis dynamics (1 paper) and Clusterin in disease pathology (1 paper). The work is most often cited by research in Oncology (233 citations), Cancer Research (118 citations), Molecular Biology (510 citations), Genetics (63 citations) and Immunology (92 citations). Alba Gonzàlez-Juncà has collaborated with scholars based in United States, Spain and Italy. Frequent co-authors include Joan Seoane, Laura Rodón, Elena Martínez‐Sáez, Isabel Cuartas, José Jimenez, David García‐Dorado, Annette M.G. Dirac, José Baselga, Claudia Aura and Vicente Peg. Their work appears in journals such as International Journal of Radiation Oncology*Biology*Physics, Nature Communications, Neuro-Oncology, Clinical Cancer Research and Nature Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.